Skip to main content
main-content

Zeitschrift

Annals of Hematology

Annals of Hematology 5/2021

Ausgabe 5/2021

Inhaltsverzeichnis ( 32 Artikel )

01.02.2021 | COVID-19 | Review Article | Ausgabe 5/2021 Zur Zeit gratis

COVID-19 pandemic and transfusion medicine: the worldwide challenge and its implications

Layal Al Mahmasani, Mohammad Hassan Hodroj, Antoine Finianos, Ali Taher

08.03.2021 | COVID-19 | Review Article | Ausgabe 5/2021 Zur Zeit gratis

Association between ABO blood types and coronavirus disease 2019 (COVID-19), genetic associations, and underlying molecular mechanisms: a literature review of 23 studies

Yujia Zhang, Rachael Garner, Sana Salehi, Marianna La Rocca, Dominique Duncan

23.03.2021 | Original Article | Ausgabe 5/2021

Opioids are not a major cause of death of patients with sickle cell disease

Samir K. Ballas

19.03.2021 | Original Article | Ausgabe 5/2021

Prospective cardiac magnetic resonance imaging survey in myelodysplastic syndrome patients: insights from an Italian network

Alessia Pepe, Michele Rizzo, Sara Galimberti, Claudia Baratè, Esther Natalie Oliva, Francesco Arcioni, Sergio Storti, Stefania Renne, Massimo Midiri, Gennaro Restaino, Vincenzo Positano, Maurizio Mangione, Antonella Meloni

10.02.2021 | Original Article | Ausgabe 5/2021

Flow cytometric analysis of peripheral blood neutrophil myeloperoxidase expression for ruling out myelodysplastic syndromes: a prospective validation study

Tatiana Raskovalova, Marie-Christine Jacob, Claude-Eric Bulabois, Clara Mariette, Laura Scheffen, Sophie Park, José Labarère

11.03.2021 | Original Article | Ausgabe 5/2021 Open Access

Acute kidney injury adversely affects the clinical course of acute myeloid leukemia patients undergoing induction chemotherapy

Olivier Ballo, Fagr Eladly, Stefan Büttner, Jan Alexander Stratmann, Sarah Rudolf, Uta Brunnberg, Eva-Maria Kreisel, Björn Steffen, Sebastian Wagner, Fabian Finkelmeier, Hubert Serve, Christian H. Brandts

02.03.2021 | Original Article | Ausgabe 5/2021 Open Access

Effects of lenalidomide on the bone marrow microenvironment in acute myeloid leukemia: Translational analysis of the HOVON103 AML/SAKK30/10 Swiss trial cohort

Magdalena M. Brune, Georg Stüssi, Pontus Lundberg, Visar Vela, Dominik Heim, Markus G. Manz, Eugenia Haralambieva, Thomas Pabst, Yara Banz, Mario Bargetzi, Rainer Grobholz, Martin Fehr, Sergio Cogliatti, Gert J. Ossenkoppele, Bob Löwenberg, Christina Biaggi Rudolf, Qiyu Li, Jakob Passweg, Luca Mazzuchelli, Michael Medinger, Alexandar Tzankov, on behalf of the Dutch-Belgian Hemato-Oncology Cooperative Group (HOVON) and Swiss Group for Clinical Cancer Research (SAKK)

19.03.2021 | Original Article | Ausgabe 5/2021 Open Access

Clinical benefit of glasdegib plus low-dose cytarabine in patients with de novo and secondary acute myeloid leukemia: long-term analysis of a phase II randomized trial

Michael Heuser, B. Douglas Smith, Walter Fiedler, Mikkael A. Sekeres, Pau Montesinos, Brian Leber, Akil Merchant, Cristina Papayannidis, José A. Pérez-Simón, Caroline J. Hoang, Thomas O’Brien, Weidong Wendy Ma, Mirjana Zeremski, Ashleigh O’Connell, Geoffrey Chan, Jorge E. Cortes

04.03.2021 | Original Article | Ausgabe 5/2021

Glasdegib in combination with low-dose Cytarabine for the outpatient treatment of relapsed or refractory acute myeloid leukemia in unfit patients

Andrius Zucenka, Kazimieras Maneikis, Birute Pugaciute, Ugne Ringeleviciute, Austeja Dapkeviciute, Linas Davainis, Guoda Daukelaite, Paulina Burzdikaite, Vytautas Staras, Laimonas Griskevicius

20.01.2021 | Original Article | Ausgabe 5/2021

Both the subtypes of KIT mutation and minimal residual disease are associated with prognosis in core binding factor acute myeloid leukemia: a retrospective clinical cohort study in single center

Wenbing Duan, Xiaohong Liu, Xiaosu Zhao, Jinsong Jia, Jing Wang, Lizhong Gong, Qian Jiang, Ting Zhao, Yu Wang, Xiaohui Zhang, Lanping Xu, Hongxia Shi, Yingjun Chang, Kaiyan Liu, Xiaojun Huang, Yazhen Qin, Hao Jiang

07.03.2021 | Original Article | Ausgabe 5/2021

Real-life comparison of nilotinib versus dasatinib as second-line therapy in chronic phase chronic myeloid leukemia patients

Emilia Scalzulli, Giovanni Caocci, Fabio Efficace, Lorenzo Rizzo, Gioia Colafigli, Alessio Di Prima, Sara Pepe, Danilo Alunni Fegatelli, Ida Carmosino, Daniela Diverio, Roberto Latagliata, Giorgio La Nasa, Maurizio Martelli, Robin Foà, Massimo Breccia

25.03.2021 | Original Article | Ausgabe 5/2021

Clinical Impact of Extranodal Metabolic Tumor Volume in 240 Diffuse Large B cell Lymphoma Patients with Extranodal Involvement

Moo-Kon Song, Joo-Seop Chung, Sung-Nam Lim, Won-Sik Lee, Sang-Min Lee, Seong-Jang Kim, Hye-Kyung Shim, Seok-Mo Lee

25.02.2021 | Original Article | Ausgabe 5/2021

Age and comorbidity are determining factors in the overall and relative survival of patients with follicular lymphoma

Pablo Mozas, Andrea Rivero, Alfredo Rivas-Delgado, Ferran Nadeu, Juan Gonzalo Correa, Carlos Castillo, Alex Bataller, Tycho Baumann, Eva Giné, Julio Delgado, Neus Villamor, Elías Campo, Laura Magnano, Armando López-Guillermo

04.03.2021 | Original Article | Ausgabe 5/2021

Whole-body low-dose computed tomography (WBLDCT) in staging and re-staging of multiple myeloma

Davide Ippolito, Teresa Giandola, Cesare Maino, Anna Pecorelli, Maria Ragusi, Marco Porta, Davide Gandola, Cammillo Talei Franzesi, Sandro Sironi

08.03.2021 | Original Article | Ausgabe 5/2021

The combination of C-Myc rearrangement and 1q21 gain is associated with poor prognosis in multiple myeloma

Yuanyuan Jin, Xiaochen Yu, Jianhua Du, Hui Li, Wenjiao Tang, Congwei Jia, Yunyan Zan, Miao Chen, Yanbin Zhang, Minhong Yu, Weiqi Rong, Daobin Zhou, Junling Zhuang

21.01.2021 | Original Article | Ausgabe 5/2021

Renal failure among multiple myeloma patients utilizing carfilzomib and associated factors in the “real world”

Hira S. Mian, Mark A. Fiala, Larysa Sanchez, Ravi Vij, Tanya M. Wildes

13.03.2021 | Original Article | Ausgabe 5/2021

Minimal residual disease monitoring and preemptive immunotherapies for frequent 11q23 rearranged acute leukemia after allogeneic hematopoietic stem cell transplantation

Jing Liu, Xiao-Hui Zhang, Lan-Ping Xu, Yu Wang, Chen-Hua Yan, Huan Chen, Yu-Hong Chen, Wei Han, Feng-Rong Wang, Jing-Zhi Wang, Yi-Fei Cheng, Ya-Zhen Qin, Kai-Yan Liu, Xiao-Jun Huang, Xiao-Su Zhao, Xiao-Dong Mo

04.03.2021 | Original Article | Ausgabe 5/2021 Open Access

Prospective analysis of BKV hemorrhagic cystitis in children and adolescents undergoing hematopoietic cell transplantation

Małgorzata Salamonowicz-Bodzioch, Jowita Frączkiewicz, Krzysztof Czyżewski, Olga Zając-Spychała, Ewa Gorczyńska, Anna Panasiuk, Marek Ussowicz, Krzysztof Kałwak, Zofia Szmit, Grażyna Wróbel, Bernarda Kazanowska, Alicja Chybicka, Bogna Ukielska-Hoffmann, Danuta Wendycz-Domalewska, Mariusz Wysocki, Magdalena Dziedzic, Jacek Wachowiak, Agnieszka Zaucha-Prażmo, Jerzy Kowalczyk, Jolanta Goździk, Jan Styczyński

12.02.2021 | Original Article | Ausgabe 5/2021

Early administration of cyclosporine may reduce the incidence of cytokine release syndrome after HLA-haploidentical hematopoietic stem-cell transplantation with post-transplant cyclophosphamide

Naoki Kurita, Tatsuhiro Sakamoto, Takayasu Kato, Manabu Kusakabe, Yasuhisa Yokoyama, Hidekazu Nishikii, Mamiko Sakata-Yanagimoto, Naoshi Obara, Yuichi Hasegawa, Shigeru Chiba

20.01.2021 | Original Article | Ausgabe 5/2021 Open Access

Umbilical cord blood transplantation can overcome the poor prognosis of KMT2A-MLLT3 acute myeloid leukemia and can lead to good GVHD-free/relapse-free survival

Juan Tong, Lei Zhang, Huilan Liu, Xiucai Xu, Changcheng Zheng, Wen Yao, Xiaoyu Zhu, Baolin Tang, Xiang Wan, Kaidi Song, Xuhan Zhang, Guangyu Sun, Zimin Sun

12.03.2021 | Original Article | Ausgabe 5/2021

Moderate-severe grade of chronic graft versus host disease and younger age (less than 45 years old) are risk factors for avascular necrosis in adult patients undergoing allogeneic hematopoietic cell transplantation

Arjun Datt Law, Sita Bhella, Ivan Pasic, Wilson Lam, Fotios V. Michelis, Armin Gerbitz, Auro Viswabandya, Rajat Kumar, Jeffrey H. Lipton, Jonas Mattsson, Dennis Dong Hwan Kim

19.11.2020 | Original Article | Ausgabe 5/2021

High lymphocyte counts before antithymocyte globulin administration predict acute graft-versus-host disease

Souichi Shiratori, Hiroyuki Ohigashi, Takahide Ara, Atsushi Yasumoto, Hideki Goto, Masao Nakagawa, Junichi Sugita, Masahiro Onozawa, Kaoru Kahata, Tomoyuki Endo, Daigo Hashimoto, Takanori Teshima

05.11.2020 | Letter to the Editor | Ausgabe 5/2021

Effective treatment with imatinib for acute B-lymphoblastic leukaemia with EBF1-PDGFRB fusion

Mirei Horiuchi, Masahiro Yoshida, Kai Yamasaki, Ryoko Sakagami, Takane Aoyama, Naoko Tatsumi, Minako Tsutsumi, Yosuke Nakaya, Hoyuri Fuseya, Takuro Yoshimura, Yoshiki Hayashi, Takafumi Nakao, Takahisa Yamane

13.01.2021 | Letter to the Editor | Ausgabe 5/2021

Venetoclax-induced panniculitis in an acute myeloid leukemia patient

Po-Wei Liao, Ren Ching Wang, Tsung-Chih Chen, Chieh-Lin Jerry Teng

20.01.2021 | Letter to the Editor | Ausgabe 5/2021

Low-density lipoprotein (LDL) and the risk of thrombotic events in essential thrombocythemia and polycythemia vera

Ivan Krečak, Hrvoje Holik, Božena Coha, Martina Morić Perić, Ivan Zekanović, Marija Valovičić Krečak, Velka Gverić-Krečak, Marko Lucijanić

24.03.2021 | Letter to the Editor | Ausgabe 5/2021

Clonal derivation of sequential seminoma and acute megakaryoblastic leukaemia

Karen H. K. Tang, Alvin H. W. Ip, Yok-Lam Kwong

30.03.2021 | Letter to the Editor | Ausgabe 5/2021

A retrospective analysis on arteritis after administration of granulocyte colony-stimulating factor

Ken Sasaki, Kensuke Matsuda, Masashi Miyauchi, Akira Honda, Arika Shimura, Yosuke Masamoto, Mineo Kurokawa

02.03.2021 | Letter to the Editor | Ausgabe 5/2021

Fatal splenic rupture after discontinuing treatment by ibrutinib and venetoclax in relapse/refractory mantle cell lymphoma

Louise Roulin, Corinne Haioun, François Lemonnier

10.03.2021 | Letter to the Editor | Ausgabe 5/2021

Does the order of busulfan and cyclophosphamide affect allogeneic stem cell transplantation related liver toxicity?

Claire Seydoux, Jakob R. Passweg, Michael Medinger

14.05.2020 | Letter to the Editor | Ausgabe 5/2021

Daratumumab for refractory warm autoimmune hemolytic anemia

Ankur Jain, D. K. Gupta

30.05.2020 | Letter to the Editor | Ausgabe 5/2021 Open Access

dsDNA from extracellular vesicles (EVs) in adult AML

Simona Bernardi, C. Zanaglio, M. Farina, N. Polverelli, M. Malagola, D. Russo

07.05.2020 | Letter to the Editor | Ausgabe 5/2021

Rosette-like formation in multiple myeloma

Masanori Aoki, Naoki Takahashi, Yoshitada Taji, Masanori Yasuda, Norio Asou, Yasuhiro Ebihara

Aktuelle Ausgaben

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise